Literature DB >> 6430610

Heterogeneity, polypeptide chain composition and antigenic reactivity of autoantibodies (F-42) that are directed against the classical pathway C3 convertase of complement and isolated from sera of patients with systemic lupus erythematosus.

M R Daha, H M Hazevoet, L A van Es.   

Abstract

F-42, an autoantibody found in the sera of some patients with systemic lupus erythematosus, was isolated from sera of seven different patients. By binding of the autoantibodies to cell bound C42, the autoantibodies were purified to homogeneity and radiolabelled with 125I. Purified preparations of 125I-F-42 were bound for at least 96% by 10(9) erythrocytes bearing C4bhuC2hu. Analysis of all 125I-F-42 preparations by SDS-PAGE demonstrated apparent mol. wts of approximately 150,000. After reduction in the presence of 8 M urea each 125I-F-42 preparation yielded heavy and light chains. The heavy chains in some instances were slightly heavier than the heavy chain of normal human IgG. The reaction of 125I-F-42 from the seven patients was positive with Sepharose bound antisera to IgG, kappa, lambda, gamma 1, gamma 2, gamma 3 and in one case to gamma 4. These studies indicate that F-42 is an autoantibody directed against antigens expressed by the classical C3 convertase, C42.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6430610      PMCID: PMC1535982     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

Review 1.  Complement.

Authors:  H J Müller-Eberhard
Journal:  Annu Rev Biochem       Date:  1975       Impact factor: 23.643

2.  Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator.

Authors:  I Gigli; T Fujita; V Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

3.  Activation of the classical pathway of complement by the C3NeF-stabilized cell-bound amplification convertase.

Authors:  M R Daha; L A van Es
Journal:  J Immunol       Date:  1979-03       Impact factor: 5.422

4.  A simplified method for cyanogen bromide activation of agarose for affinity chromatography.

Authors:  S C March; I Parikh; P Cuatrecasas
Journal:  Anal Biochem       Date:  1974-07       Impact factor: 3.365

5.  Activation of the classical complement pathway by nephritic factor bound to the alternative pathway C3/C5 convertase.

Authors:  A T Sobel; N R Cooper; R D Schreiber
Journal:  J Immunol       Date:  1979-01       Impact factor: 5.422

6.  Heterogeneity, polypeptide chain composition and antigenic reactivity of C3 nephritic factor.

Authors:  M R Daha; K F Austen; D T Fearon
Journal:  J Immunol       Date:  1978-04       Impact factor: 5.422

7.  Cleavage of C2 by C1s into the antigenically distinct fragments C2a and C2b: demonstration of binding of C2b to C4b.

Authors:  S Nagasawa; R M Stroud
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

8.  The role of complement in the binding and degradation of immunoglobulin aggregates by macrophages.

Authors:  A Kijlstra; L A van Es; M R Daha
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

9.  The second component of human complement: its isolation, fragmentation by C'1 esterase, and incorporation into C'3 convertase.

Authors:  M J Polley; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1968-09-01       Impact factor: 14.307

10.  Chromatographic resolution of the first component of human complement into three activities.

Authors:  I H LEPOW; G B NAFF; E W TODD; J PENSKY; C F HINZ
Journal:  J Exp Med       Date:  1963-06-01       Impact factor: 14.307

View more
  2 in total

1.  Guinea pigs with inherited deficiencies of complement components C2 or C4 have characteristics of immune complex disease.

Authors:  E C Böttger; T Hoffmann; U Hadding; D Bitter-Suermann
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

2.  Different Aspects of Classical Pathway Overactivation in Patients With C3 Glomerulopathy and Immune Complex-Mediated Membranoproliferative Glomerulonephritis.

Authors:  Marloes A H M Michels; Nicole C A J van de Kar; Sanne A W van Kraaij; Sebastian A Sarlea; Valentina Gracchi; Flore A P T Engels; Eiske M Dorresteijn; Johannes van der Deure; Caroline Duineveld; Jack F M Wetzels; Lambertus P W J van den Heuvel; Elena B Volokhina
Journal:  Front Immunol       Date:  2021-08-11       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.